The Spondyloarthritis Research Consortium of Canada registry for spondyloarthritis

Journal of Rheumatology

Volumn 38, Issue 7, 2011, Pages 1343-1348

  Gladman, Dafna D ^a   Rahman, Proton ^b   Cook, Richard J ^c   Shen, Hua ^c   Zummer, Michel ^d   Thomson, Glen ^e   Nair, Bindu ^f   Rohekar, Sherry ^g   Ayearst, Renise ^h   Inman, Robert D ^a   Maksymowych, Walter P ⁱ  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^e Thomson House Medical Consultants   (Canada)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h TORONTO WESTERN HOSPITAL   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ankylosing spondylitis; Database; Psoriatic arthritis; Reactive arthritis; Spondyloarthritis; Undifferentiated spondyloarthritis

Indexed keywords

ADULT; ARTICLE; CANADA; DATA BASE; DISABILITY; DISEASE ACTIVITY; DISEASE REGISTRY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MEDICAL SOCIETY; PRIORITY JOURNAL; QUALITY OF LIFE; SPONDYLOARTHRITIS; SPONDYLOSIS; TREATMENT RESPONSE;

ADULT; BIOLOGICAL MARKERS; CANADA; CYTOKINES; DATABASES AS TOPIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPONDYLARTHRITIS;

EID: 79960018707     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101102     Document Type: Article

References (37)

1. Gladman DD, Cook RJ, Schentag C, Feletar M, Inman RD, Hitchon C, et al. The clinical assessment of patients with psoriatic arthritis: results of a validation study of the SpondyloArthritis Research Consortium of Canada (SPARCC). J Rheumatol 2004;31:1126-31. (Pubitemid 38715888)
2. Maksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, et al. Canadian Rheumatology Association consensus on the use of anti-TNFα- directed therapies in the treatment of spondyloarthritis. J Rheumatol 2003;30:1356-63. (Pubitemid 36666368)
3. Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Krishnananthan R, Stone M, et al. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis Rheum 2005;53:502-9. (Pubitemid 41278914)
4. Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, et al. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 2005;53:703-9. (Pubitemid 41463835)
5. Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 2009;68:948-53.
6. Helliwell PS, Firth J, Ibrahim GH, Melsom RD, Shah I, Turner DE. Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005;32:1745-50. (Pubitemid 41324815)
7. Maksymowych WP, Mallon C, Richardson R, Conner-Spady B, Jauregui E, Chung C, et al. Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index (EDASMI). Arthritis Rheum 2006;55:575-82. (Pubitemid 44289877)
8. Gladman DD, Inman R, Cook R, van der Heijde D, Landewe RB, Braun J, et al. International Spondyloarthritis Inter-Observer Reliability Exercise - The INSPIRE Study: I. Assessment of spinal measures. J Rheumatol 2007;34:1733-9. (Pubitemid 47267618)
9. Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, et al. International Spondyloarthritis Inter-Observer Reliability Exercise - The INSPIRE Study: II. Assessment of peripheral joints, enthesitis and dactylitis. J Rheumatol 2007;34:1740-5. (Pubitemid 47267619)
10. Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007;34:123-9.
11. Fries JF, Kraines RG, Holman HR. Measurment of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
12. Husted J, Gladman DD, Long JA, Farewell VT, Cook R. Validating the SF-36 health questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-7. (Pubitemid 27153417)
13. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
14. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
15. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6. (Pubitemid 36005790)
16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6. (Pubitemid 24194579)
17. Husted JA, Tom BD, Schentag CT, Farewell VT, Gladman DD. Occurrence and correlates of fatigue in psoriatic arthritis (PsA). Ann Rheum Dis 2009;68:1553-8.
18. Chandran V, Bhella S, Schentag C, Gladman DD. Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue Scale is valid in patients with psoriatic arthritis (PsA). Ann Rheum Dis 2007;66:936-9.
19. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43. (Pubitemid 32675374)
20. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
21. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
22. Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770-6.
23. Taylor WJ, Gladman DD, Helliwell PS, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
24. Maksymowych WP, Rahman P, Reeve J, Gladman D, Peddle L, Inman RD. The interleukin-1 locus is associated with susceptibility to ankylosing spondylitis: a Spondyloarthritis Research Consortium of Canada (SPARCC) analysis of 3 Canadian populations. Arthritis Rheum 2006;54:974-85.
25. Sims AM, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou CT, Doan T, et al. Prospective meta-analysis of IL-1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008;67:1305-9.
26. Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23R variants with ankylosing spondylitis. Arthritis Rheum 2008;58:1020-5. (Pubitemid 351564003)
27. Rahman P, Inman RD, Maksymowych WP, Reeve JP, Peddle L, Gladman DD. Association of interleukin-23R variants with psoriatic arthritis. J Rheumatol 2009;36:137-40.
28. Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009;60:1317-23.
29. Uddin M, Maksymowych W, Inman R, Gladman D, Sturge M, Peddle L, et al. Marked differences in genetic structure of two geographically distinct Canadian populations [abstract]. J Rheumatol 2008;35:1192.
30. Inman RD, Maksymowych WP, Gladman DD, et al. Association of STAT4 variants and ankylosing spondylitis (AS). Ann Rheum Dis 2008;67 Suppl II:514.
31. Maksymowych WP, Inman RD, Reeve JP, Gladman DD, Pope AM, Rahman P. Association of MSX-2 variants and ankylosing spondylitis. Ann Rheum Dis 2009;68 Suppl 3:184.
32. Rahman P, Inman RD, Maksymowych WP, et al. Association of IRF5 polymorphisms in psoriatic arthritis. Ann Rheum Dis 2008;67 Suppl II:530.
33. Maksymowych WP, Wichuk S, Rahman P, Gladman D, Inman RD. Multiplex assay of a panel of 58 biomarkers in ankylosing spondylitis: Identification of High priority candidates for prediction of structural damage. Ann Rheum Dis 2010;69 Suppl 2.
34. Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, et al. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology 2010;49:1399-405.
35. Chandran V, Shen H, Pollock R, Pellett F, Schentag CT, Cook RJ, Gladman DD. Soluble biomarkers predict response to anti-tumour necrosis factor (TNF) therapy in psoriatic arthritis (PsA) [abstract]. Arthritis Rheum 2009;60 Suppl:S666.
36. Davis A, Palaganas M, Badley E, Inman R, Gladman DD, Gignac M. What matters to people in spondyloarthritis (SpA): Measuring the importance of valued life activities [abstract]. Arthritis Rheum 2007;56 Suppl:S591.
37. Maksymowych P, Gladman D, Rahman P, Boonen A, Bykerk V, Choquette D, et al. The Canadian Rheumatology Association (CRA)/Spondyloarthritis Research Consortium of Cananda (SPARCC) treatment recommendations for spondyloarthritis: A national multidisciplinary stakeholder project [abstract]. J Rheumatol 2007;34:1622.